21.08.2019 14:59:16

Perrigo Settles Patent Litigation On Generic Version Of Nascobal Nasal Spray

(RTTNews) - Perrigo Company plc (PRGO) said that it has settled its Hatch-Waxman litigation relating to Nascobal Nasal Spray brought by Endo Pharmaceuticals Inc. It did not disclose terms of the settlement.

According to IQVIA, annual market sales for the 12-months ending June 2019 were $90 million.

Perrigo Executive Vice President and President Rx Pharmaceuticals Sharon Kochan said, ".... Our R&D, operations and legal teams continue to work diligently and relentlessly to introduce new generic products that provide savings to patients and healthcare systems."

Analysen zu Perrigo Company PLCmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Perrigo Company PLC 23,83 1,06% Perrigo Company PLC